Recent Publications

• Impact of public health and social measures on contact dynamics during a SARS-CoV-2 Omicron variant outbreak in Quanzhou, China, March to April 2022.
  Guo Yichao, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2023 0 0.
  
• SARSCoV2 Omicron (B. 1.1. 529) recent updates and challenges worldwide.
  Das Rina, et al. Infectious disorders drug targets 2023 0 0.
  
• Implementation of genomic surveillance of SARS-CoV-2 in the Caribbean: Lessons learned for sustainability in resource-limited settings.
  Nikita S D Sahadeo et al. PLOS global public health 2023 3 (2) e0001455
  
• Investigation of an outbreak of COVID-19 among U.S. military personnel and beneficiaries stationed in the Republic of Korea, June-July 2021.
  Shilpa Hakre et al. PLOS global public health 2023 3 (5) e0000236
  
• Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis.
  Deborah Cromer et al. Nature communications 2023 3 (1) 1633
  
  We find that predicted neutralising antibody titres are strongly correlated with observed vaccine effectiveness against symptomatic (Spearman [Formula: see text] = 0.95, p < 0.001) and severe (Spearman [Formula: see text] = 0.72, p < 0.001 for both) COVID-19 and that the loss of neutralising antibodies over time and to new variants are strongly predictive of observed vaccine protection against severe COVID-19.
• Robust models of disease heterogeneity and control, with application to the SARS-CoV-2 epidemic.
  Johnson Kory D, et al. PLOS global public health 2023 0 0. (5) e0000412
  
• Fast Evaluation of Viral Emerging Risks (FEVER): A computational tool for biosurveillance, diagnostics, and mutation typing of emerging viral pathogens.
  Stromberg Zachary R, et al. PLOS global public health 2023 0 0. (2) e0000207
  
• Genomic epidemiology of SARS-CoV-2 during the first four waves in Mozambique.
  Ismael Nalia, et al. PLOS global public health 2023 0 0. (3) e0001593
  
• Neo-epidemiological machine learning based method for COVID-19 related estimations.
  Bodaghie Mouhamad, et al. PloS one 2023 0 0. (3) e0263991
  
• COVID-19 Diagnosis and SARS-CoV-2 Strain Identification by a Rapid, Multiplexed, Point-of-Care Antibody Microarray.
  Heggestad Jacob T, et al. Analytical chemistry 2023 0 0.
  
• People who catch Omicron are less likely to get Long Covid Vaccination, virus biology may be driving down risk
  J Couzin-Frankel, Science, March 2023
  
  After Omicron began spreading in late 2021, COVID-19 deaths became a rarity even among frail and immunocompromised patients, he says. And infections now carry a lower threat of lingering complications. “These patients with Omicron, they’re much less likely to get Long Covid,” says Willan, whose patients are overwhelmingly vaccinated. Earlier this month, he reported in the British Journal of Haematology that his patients’ risk of Long Covid symptoms 3 months after infection had dropped from 46% with the original coronavirus strain and another called Alpha, to 35% with the Delta variant, to 14% with Omicron.
• Genome surveillance of SARS-CoV-2 variants and their role in pathogenesis focusing on second wave of COVID-19 in India.
  Sarkar Poulomi, et al. Scientific reports 2023 0 0. (1) 4692
  
• Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak in Shanghai.
  Fu Ziyu, et al. Frontiers of medicine 2023 0 0. 1-14
  
• Combining viral genomics and clinical data to assess risk factors for severe COVID-19 (mortality, ICU admission, or intubation) amongst hospital patients in a large acute UK NHS hospital Trust.
  Foxley-Marrable Max, et al. PloS one 2023 0 0. (3) e0283447
  
• Comment on Risk and benefit of mRNA COVID-19 vaccines for Omicron variant.
  Kleebayoon Amnuay, et al. American journal of epidemiology 2023 0 0.
  
• Stealth Omicron: A Novel SARS-CoV-2 Variant That Is Insensitive to RT-qPCR Using the N1 and N2 Primer-Probes.
  Mori Hideo, et al. Cureus 2023 0 0. (3) e36373
  
• SARS-CoV-2 Omicron variant shedding during respiratory activities.
  Tan Kai Sen, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2023 0 0.
  
• SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children.
  Brian W McCrindle et al. The New England journal of medicine 2023 3
  
  The features of MIS-C at presentation were more often similar to the features of Kawasaki’s disease among patients hospitalized with SARS-CoV-2 infection during the more recent variant periods than among those during the earlier periods; however, without a definitive diagnostic test for either condition, it remains to be determined whether this represents a true change in phenotype or an increase in the number of patients with Kawasaki’s disease who meet the criteria for MIS-C through concurrent but unrelated SARS-CoV-2 infection.
• Real-World Association Between mRNA Vaccination and Infection From the Omicron Strain of SARS-CoV-2: A Population-Level Analysis.
  Plaxco Allison P, et al. AJPM focus 2023 0 0. (1) 100010
  
• Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron.
  Scott Burkholz et al. Communications biology 2023 3 (1) 288